HEROPHILUS
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90633212
- Registration number
- 6771218
- Mark type
- Stylized text
- Filed
- 08 Apr 2021
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: research and development of novel neuro-related drugs, namely, neurotherapeutics, therapeutics and pharmaceuticals; scientific research and development services in the field of human biology; pharmaceutical drug discovery and development services; platform as a service (PAAS) featuring drug discovery computer software platforms for patient-derived organoids and complex in vitro models for purposes of neurotherapeutic analysis, discovery and development
Owner
- HEROPHILUS, INC., San Francisco, CA, US
- HEROPHILUS, INC., San Francisco, CA, US
- HEROPHILUS, INC., San Francisco, CA, US
Prosecution history
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Feb 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Nov 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Nov 2021 — NON-FINAL ACTION E-MAILED
- 29 Nov 2021 — NON-FINAL ACTION WRITTEN
- 29 Nov 2021 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 29 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Nov 2021 — ASSIGNED TO EXAMINER